Monthly shot vs. daily pills: new hope for cancer patients with dangerous blood clots
Disease control
Terminated
This study tested whether a monthly injection (abelacimab) works better than twice-daily pills (apixaban) to prevent recurring blood clots in people with cancer. It aimed to see if the monthly option reduces both clot recurrence and bleeding risks while being more convenient for …
Phase: PHASE3 • Sponsor: Anthos Therapeutics, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC